Gabelli & Co Investment Advisers’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-192,650	Closed	-$3.17M	–	298
2023 Q4	$3.17M	Buy	+192,650	New	+$3.03M	0.59%	38

Gabelli & Co Investment Advisers's ORTX Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 192,650 shares — an estimated $3.17M sold.

Gabelli & Co Investment Advisers first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $3.17M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Gabelli & Co Investment Advisers reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 192,650 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $3.17M.
Gabelli & Co Investment Advisers first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Orchard Therapeutics plc American Depositary Shares position peaked at $3.17M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.